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Biosynthesis of Complement C4 Messenger RNA in Normal Human Kidney 
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Abstract. Complementary D N A (cDNA) probes were used to investigate the extrahepatic production of the major 
histocompatibility complex (MHC)-linked complement components C4, factor B and C2 in various normal human 
tissues. The presence of the corresponding messenger RNA (mRNA) was tested by Northern blot analysis. Comple-
ment C4 m R N A was found in liver, and with high intensity also in normal kidneys. In contrast, no C2 mRNA and only 
very low amounts of factor B m R N A could be detected in the kidney. Slot blot hybridization was performed to 
quantitate the amount of C4 mRNA, and the intensity of C4 mRNA hybridization in the kidney samples was about 
25% compared with liver RNA. C4-specific transcripts were not present in isolated glomeruli but in the renal 
interstitium. Other human tissues, such as tonsil, spleen, thymus, brain, lung and peripheral mononuclear cells, 
contained no C4 m R N A . Low amounts of C4 m R N A were found in colon, thyroid gland, lymph node and breast 
carcinoma. The results obtained with lung, where C2 mRNA was found but no C4 mRNA, further indicate an 
independent, tissue-specific regulation of the class III gene expression. The results, showing that the complement C4 
genes are transcribed very efficiently in normal human kidney, suggest a direct role of complement C4 in renal 
pathogenesis. 
Introduction 
The complement components C4, factor B and C2 are 
encoded on chromosome 6 between the class I and class 
II genes of the major histocompatibility complex (MHC) 
[1], Recent studies have established the associations be-
tween alleles of the MHC-linked complement genes and 
various autoimmune diseases [2]. The fourth component 
of human complement is controlled by two highly poly-
morphic genes, C4A and C4B [3], and several forms of 
primary glomerulonephritis were found in association 
with certain alleles of C4 or with partial deficiency of C4 
[4, 5]. This peculiar disease association raised the ques-
tion, of whether the structural variants of C4 might be 
directly involved in the pathogenesis of renal autoim-
mune diseases. Using an immunoperoxidase staining 
technique and monoclonal antibodies against C4, we 
have recently demonstrated the presence of both isotypic 
components C4A and C4B in glomeruli of normal human 
kidney [6]. The question however remained of whether 
complement C4 is passively adsorbed, or locally pro-
duced in human kidney. 
Complement components in the serum are primarily 
produced in the liver [7]. However, extrahepatic produc-
tion has also been noted. Already in 1965, using radiolab-
eled amino acids and immune electrophoresis of tissue 
culture supernatants, Thorbecke et al. [8] have provided 
evidence that several normal tissues produce comple-
ment C3 and to a less extent complement C4. In rhesus 
monkeys e.g. C4 production was also found in normal 
lung, mammary gland, thyroid gland and kidney. Investi-
gating adult human tissues, thyroidea, breast and lung 
were found to produce complement C4 in addition to 
liver [9, 10]. In these studies mononuclear phagocytes 
were identified as complement source, thus explaining 
also the local synthesis of complement components in 
inflamed tissues such as rheumatoid synovium [11]. The 
available complementary D N A (cDNA) probes specific 
for the MHC class III proteins C4, factor B and C2 [12-14] 
enabled us to readdress the question of biosynthesis of 
these components by Northern blot hybridization. Here 
we report that normal human kidney contains C4 mes-
senger RNA (mRNA) in comparable amounts to human 
liver. 
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Fig. 1. Presence of C4 mRNA in human 
kidney and liver. Northern blot analysis of 10 
ug of total RNA prepared from various human 
organs (except kidney II*, where 7 ug were 
applied) and hybridization with C4d-specific 
cDNA probe Alu-7 (a), b Total RNA from 
mouse liver is included. PBMNC = Peripheral 
blood mononuclear cells. 28s and 18s repres-
ent the large and small subunit of ribosomal 
RNA. Different numbers refer to different pa-
tients. 
Methods 
Tissue Samples 
Human tissue specimens obtained during surgery were immedi-
ately snap frozen in liquid nitrogen and transferred to the laboratory 
for further processing. 
Kidney tissue was obtained from 5 patients (ranging in age from 
44 to 71 years) undergoing nephrectomy due to renal carcinoma. 
Only histologically normal, tumor-free sections, as judged by light 
microscopy were used for preparation of total RNA. One sample 
was also obtained from renal carcinoma. Whole glomeruli were 
isolated from renal cortex cut into small pieces. Tubular and fibrous 
material was removed by subsequent sieving through nylon meshes 
of different pore size (500 and 250 urn, respectively). Glomeruli were 
retained on and rinsed from a mesh with 125 urn opening size. 
Ice-cold media were used throughout. Tonsils were obtained from 
children with adenoid hyperplasia, thymus was obtained during 
open heart surgery. Thyroid gland was removed either totally be-
cause of carcinoma or partially due to toxic adenoma. Spleens were 
taken from patients after trauma. Histologically normal colon was 
taken from colectomies due to carcinoma. During removal of car-
cinoma, normal tissue specimens were obtained from lung, liver, 
lymph nodes, and also two samples from breast carcinoma. Peri-
pheral blood mononuclear cells were isolated by density gradient 
centrifugation. Brain was obtained at autopsy. 
Preparation of Total RNA and Hybridization with cDNA Probes 
Total RNA was prepared from each tissue sample by standard 
procedures [15]. Ten micrograms of total RNA were separated on a 
formamide agarose gel and transferred to nylon membranes. cDNA 
probes were labeled with 32P according to the method of Feinberg 
and Vogelstein [16]. The Northern blots were hybridized overnight at 
65 °C with labeled cDNA probes at an activity of 2-5 x 106 cpm/ml 
in 3 x saline sodium citrate buffer ( 2 0 x S S C = 3 M NaCl, 0.3 M 
Na-citrate), 10 x Denhardt's solution, 0.1% sodium dodecyl sulfate 
(SDS), 0.1% sodium pyrophosphate, 10% dextran sulfate, 50 g/ml 
denatured salmon sperm DNA. Washing was performed stepwise 
for 30 min at 65 °C in buffers with decreasing SSC concentration, 
reaching 0.1% SSC, 0.1% SDS during the last step. 
C4, Factor B- and C2-Specific cDNA Probes 
Initially, Alu-7, a cDNA probe of 300 base pairs (BP) which is 
specific for the amino acid sequence of C4d of both C4 isotypes [12] 
was employed and later pAT-A, which contains the full-length 
5.5-kb C4A transcript [17]. The 515 BP cDNA probe FBI is specific 
for factor B [13] and the 900 BP cDN A probe pC2-6 is specific for C2 
[14]. 
Bacteria containing the relevant class III cDNA clones were 
kindly provided by Dr. M.C. Carroll (Oxford) and Dr. P. Schneider 
(Mainz). The plasmids were isolated from 11 overnight cultures by 
the alkaline lysis method [18] and purified on a cesium-chloride 
gradient. Fifty micrograms of the plasmids were digested with the 
appropriate restriction enzymes to cut out the cDNA insert, and 
separated on a preparative 0.7% agarose gel. The cDNA fragments 
were isolated from the gel by electroelution. 
Slot blot hybridization, using decreasing amounts of total RNA, 
was done according to the method of Kafatos et al. [19]. Control 
hybridization was performed with a human actin-specific cDNA 
probe [20]. 
Results 
Detection of C4 mRNA in Human Kidney 
Total RNA was prepared from five different kidney 
samples and was analyzed for the presence of C4 m R N A 
by Northern and slot blot hybridization with two C4 
c D N A probes. Distinct hybridization with the C4d-spe-
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Fig. 2. Intensity of C4 mRNA biosynthesis in various human 
organs. Slot blot analysis of total RNA, hybridized with full length 
C4cDNA probe pAT-A. Kidney IV and Vand colon I and II refer to 
different patients. Exposure was 24 h. (a) Control hybridization with 
actin-specific cDNA probe (b) is shown. 
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Fig. 3. Presence of C2 mRNA in 
human liver and lung. Northern 
blot analysis of total RNA and hyb-
ridization with C2-specific cDNA 
probe pC2-6. Different numbers 
refer to different patients. 
cific cDNA probe Alu-7 and the full-length C4 cDNA 
probe pAT-A was obtained with each kidney sample. 
Figure 1 shows the comparative hybridization to RNA 
from various human organs, including liver, kidney, iso-
lated glomeruli, thymus, tonsil, spleen, brain (fig. la), 
peripheral blood mononuclear cells, renal carcinoma, 
breast carcinoma and mouse liver (fig. lb). The C4 cDN A 
probe hybridizes to RNA of approximately 5.5 kb length 
in the liver sample and also to kidney RNA, thus demon-
strating the presence of C4-specific transcripts in the 
different kidneys analyzed. Interestingly, only whole re-
nal cortex contained C4 mRNA, whereas isolated glom-
eruli were consistently negative. No C4 transcripts were 
detected with RNA preparat ions from thymus, tonsil, 
spleen, brain, peripheral blood mononuclear cells, renal 
carcinoma, breast carcinoma and mouse liver. 
In order to quantitate the amount of C4 mRNA, slot 
blot hybridization was performed, using decreasing 
amounts of total RNA (10, 5 and 2.5 ug, respectively) per 
slot and the full length c D N A pAT-A as probe. A strong 
hybridization signal is displayed by liver RNA, whereas 
the intensity of C4 mRNA hybridization in two kidney 
samples is approximately 25% of the liver signal (fig. 2a). 
Again, no C4 m R N A is detected in isolated glomeruli. 
Very low amounts of C4 m R N A are found in RNA 
preparations from two colon samples, from lymph node 
and from thyroid gland. Weak hybridization is seen in the 
RNA isolated from breast carcinoma. Lung, tonsil and 
spleen are negative. In order to show that all RNA pre-
-2.6 kb 
Fig. 4. Presence of factor B 
mRNA. Appearance of weak hybri-
dization signals with cDNA probe 
FBI after prolonged exposure (48 h) 
in RNA preparations from lung, 
thyroid gland and two kidney sam-
ples. Different numbers refer to dif-
ferent patients. 
parations used in this study were of equal quality and that 
roughly equal amounts of total RNA were tested, a con-
trol hybridization was performed with a human actin-
specific probe. In all samples actin mRNA of 1.8 kb 
length is present and comparable signals are obtained in 
slot blot hybridization (fig. 2b). This result demonstrates 
that the failure to detect complement mRNA in the sam-
ples (e.g. in isolated glomeruli) is not due to degraded or 
too little RNA applied. 
Detection of C2 mRNA and Factor B mRNA by Northern 
Blot Analysis 
It was then of interest to investigate whether normal 
human kidney would also transcribe the class III genes 
coding for complement components C2 and factor B. For 
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this purpose, the Northern blots were hybridized with the 
C2-specific cDN A probe pC2-6 and the factor B-specific 
probe FBI, respectively. As shown in figure 3, C2 tran-
scripts of 2.8 kb length are present in liver and in lung, 
whereas two kidney samples and thyroid gland are nega-
tive. In contrast, only liver RNA hybridizes strongly with 
the factor B-specific cDNA probe, yielding a band at 2.6 
kb. After prolonged exposure, a weak signal is also ob-
served in the lung and kidney RNA preparations (fig. 4). 
Discussion 
Hybridization techniques using cDNA probes have 
already allowed to demonstrate the renal production of 
proteins such as factor VIII, Tamm-Horsfall glycopro-
tein, a-fetoprotein and albumin [21-23]. In this study we 
were interested in the extrahepatic production of the 
M HC-linked complement components. For this purpose, 
we investigated various human organs for the presence of 
C4, factor B and C2 mRNA by Northern blot and slot blot 
analyses. A high amount of C4 mRN A was found in liver, 
and surprisingly a signal of remarkable intensity ap-
peared also in normal human kidney. Renal carcinoma 
was devoid of C4 mRNA. No C2 mRNA and only very 
low amounts of factor B mRNA could be detected in 
human kidney. The presence of C4 mRNA strongly sug-
gests that the C4 protein is locally synthesized in the 
kidney. These results confirm the early observations by 
Thorbecke et al. [8] in rhesus monkeys. Biosynthesis of C4 
mRNA does, however, not take place in glomeruli but in 
the interstitium, as no C4-specific transcripts were pres-
ent in RNA extracted from isolated glomeruli. 
Within the interstitium, the tubular system is the most 
likely source of complement production. Macrophages, 
as another possible source, can be excluded, since we 
(own observation) and others [24] could not identify 
interstitial macrophages in normal human kidney with 
immunohistological techniques and no C4 mRNA could 
be detected in organs known to contain numerous tissue 
macrophages such as tonsil, spleen and lung. When, 
however, murine lupus was investigated, the increased 
local production of complement proteins C3, factor B, C2 
and C4 was caused by macrophages infiltrating the dis-
eased organs, primarily the kidneys [25]. Using an im-
munoperoxidase staining technique and several mono-
clonal antibodies against complement C4, we recently 
demonstrated the presence of C4 in all normal human 
glomeruli [6]. The question then arose of whether the 
glomeruli themselves would produce the detected C4. 
The present study shows that the glomeruli do not tran-
scribe the C4 gene; the glomerular C4 protein is therefore 
a deposit which is passively absorbed. It should also be 
noted that although the renal interstitium is the obvious 
site of C4 production, immunoperoxidase staining with 
monoclonal anti-C4 reagents was consistently negative 
[6]. This finding is in agreement with the results obtained 
with sections from human liver. Despite the C4 produc-
tion by hepatocytes, as confirmed by the presence of C4 
mRNA, we could not detect C4 protein in liver tissue by 
immunoperoxidase staining. And to our knowledge the 
immunohistological presence of C4 in human liver has 
not been reported so far. 
When additional normal human tissues were investi-
gated for the presence of C4 mRNA, brain and thymus 
were completely negative, whereas lymph node, colon 
and thyroid gland contained a low amount of C4 mRNA. 
The results obtained with lung, where C2 mRNA was 
found but no C4 mRNA, indicate an independent, tissue-
specific regulation of the class III gene expression. 
Similar to human liver, where a genetically deter-
mined low production of C4 is predisposing to the devel-
opment of autoimmune chronic active hepatitis [26], the 
local presence and autochthonous production of C4 
might be of relevance also for the pathogenesis of renal 
diseases. The classical pathway of complement activa-
tion, involving the components CI, C4 and C2, resulting 
in the formation of the C3-convertase, is a powerful 
mechanism for the elimination of immune complexes 
[27]. It is therefore important to determine, whether the 
'renal complement' enters the circulation and whether it 
is protective against the accumulation and deposition of 
immune complexes in the kidney. 
With respect to the putative tubular production of C4, 
there is also the possibility of excretion into the tubular 
lumen and finally into urine. In vitro experiments have 
already shown production of CI components by epithel-
ial cells from the urogenital tract including renal pelvis 
[28]. We have therefore examined normal urine speci-
mens for the presence of C4 by protein precipitation 
followed by immunoblott ing and C4 protein could be 
clearly detected [data not shown]. With this approach, it 
is impossible, however, to determine, whether the C4 
protein, although having a molecular weight of 200,000 
daltons is derived from glomerular filtration, from actual 
tubular secretion or from both. With regard to the anti-
bacterial and antiviral action of complement [29], another 
important task could therefore be the participation in the 
local protection against interstitial or ascending renal 
infection. 
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In conclusion, the results showing a very efficient tran-
scription of the complement C4 genes in normal human 
kidney suggest a direct role of complement C4 in renal 
pathogenesis. 
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